维普中文期刊产品整合服务
253篇 您的检索式:作者名="GIUGLIANO RP"
    题名 作者 年代 出处 被引量
1Early versus delayed, provisional eptifibatide in acute coronary syndromes 显示文摘Giugliano RP White JA Bode C 2009N Engl J Med2009,360,21:1
2Edoxaban versus warfarin in patients with atrial fibrillation显示文摘Giugliano RP Ruff CT Braunwald E 2013N Engl J Med2013,369,22:1
3Early versus delayed, provisional eptifibatide in acute coronary syndromes显示文摘Giugliano RP White JA Bode C 2009N Engl J Med2009,360,21:1
4Ettlcacy and safety of edoxaban for themanagement of elderly patients with atrial fibrillation: ENGAGE AF-TIMI 48 显示文摘Kato ET Giugliano RP Ruff CT 2014Circulation2014,130,16:1
5Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effec- tive aNticoaGulation with factor xA next GEneration in Atrial Fi- briliation-Thrombolysis In Myocardial Infarction study 48 ( EN- GAGE AF-TIMI48)显示文摘RUFF CT GIUGLIANO RP ANTMAN EM 2010Am Heart J2010,160,4:1
6Edoxaban versus warfarin in patients with atrial fibrillation显示文摘Giugliano RP Ruff CT Braunwald E 2013N EnglJ Med2013,369,:1
7Concomitant use of antiplatelet therapy with edoxaban or warfarin in patients with atrial fibrillation in the ENGAGE AF- TIMI 48 trial显示文摘Xu H Ruff CT Giugliano RP 2014Circulation2014,130,19:1
8Baseline low- density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lnwering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy- Thrombolysis In Myocardial Infarction 22) analysis 显示文摘Giraldez RR Giugliano RP Mohanavelu S 2008J Am Coil Cardiol2008,52,11:1
9Comparison of a 60-versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarc-tion显示文摘De Lemos JA Antman EM Giugliano RP 2000Am J Cardiol2000,86,:1
10Are PCSK9 inhibitors the next breakthrough in the cardiovascular field? 显示文摘Giugliano RP Sabatine MS 2015J Am Coil Cardiol2015,65,24:1
11Association ofhemoglobin levels with clinical outcomes in acute coronarysyndromes显示文摘Sabatine MS Morrow DA Giugliano RP 2005Circulation2005,111,16:1
12Degree of residual stenosis in the culprit coronary artery after thmmbolytic administration( thrembolysis in myocardial infarction trials显示文摘Llevadot J Giugliano RP McCabe CH 2000Am J Cardiol2000,85,12:1
13Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes显示文摘Yeh RW W/viott SD Giugliano RP 2007Am J Cardiol2007,100,12:1
14Novel biomarkers in cardiovascular disease:update 2010显示文摘Hochholzer W Morrow DA Giugliano RP 2010Am Heart J2010,160,4:1
15Edoxaban versus warfarin in patients with atrial fibrillation 显示文摘Giugliano RP Ruff CT Braunwald E 2013N Engl J Med2013,369,22:1
16Left atrial structure and function in atrial fibrillation: ENGAGE AF- TIMI 48显示文摘Gupta DK Shah AM Giugliano RP 2014Eur Heart J2014,35,22:1
17Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial) : comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes显示文摘Cannon CP Giugliano RP Blazing MA 2008Am Heart J2008,156,5:1
18Efficacy and safety of evolocumab in reducing lipids and cardio- vascular events显示文摘Sabatine MS Giugliano RP Wiviott SD 2015N Engl J Med2015,372,16:1
19Ezetimibe added to statin therapy after acute coronary syndromes显示文摘Cannon CP Blazing MA Giugliano RP 2015N Engl J Med2015,372,25:1
20The year in non-ST-segment elevation acute coronary syndromes 显示文摘Giugliano RP Braunwald E 2006J Am Coll Cardiol2006,48,2:1
返回顶部 每页显示:
共13页 首页 上一页 第1页 下一页 末页 /13 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费